Yarrow Bioscience
YARW
50 hedge funds and large institutions have $213M invested in Yarrow Bioscience in 2026 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 15 increasing their positions, 3 reducing their positions, and 22 closing their positions.
9,127% more capital inflows, than outflows
Capital inflows: $316M | Capital outflows: $3.42M
400% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 3
310.57% more ownership
Funds ownership: 43.52% → 354.09% (+311%)
36% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 22
19% more funds holding
Funds holding: 42 → 50 (+8)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Logos Global Management
San Francisco,
California
|
+$35M |
| 2 |
Bellevue Group
Kuesnacht,
Switzerland
|
+$34.1M |
| 3 |
Perceptive Advisors
New York
|
+$27.7M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$25.2M |
| 5 |
SL
Siren LLC
Greenwich,
Connecticut
|
+$23M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Shay Capital
New York
|
-$948K |
| 2 |
Deeter Investments
Austin,
Texas
|
-$651K |
| 3 |
T3 Companies
New York
|
-$615K |
| 4 |
LCM
Lynx1 Capital Management
San Juan,
Puerto Rico
|
-$360K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$248K |
YARW Hedge Fund Activity: Q3 2026 in Review
50 of the 8,227 institutional investors tracked by Wall St. Rank reported a position in Yarrow Bioscience (YARW) for Q3 2026, worth a combined $213M — up 2,154% from $9.44M a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new YARW positions and 22 closed out — a net gain of 8 holders — while 15 added to existing stakes and 3 trimmed.
The largest buyer was Logos Global Management, opening a new position worth an estimated $35M. The largest seller was Shay Capital, exiting entirely with an estimated $948K sold.
- 50 institutional investors held Yarrow Bioscience (YARW) as of Q3 2026, up from 42 in Q2 2026.
- Funds reported $213M of Yarrow Bioscience stock for Q3 2026, up 2,154% quarter-over-quarter.
- 30 funds opened new Yarrow Bioscience positions in Q3 2026 and 22 closed out, a net change of +8 holders.
- The largest Yarrow Bioscience buyer in Q3 2026 was Logos Global Management, an estimated $35M added.
- The largest Yarrow Bioscience seller in Q3 2026 was Shay Capital, an estimated $948K sold.
Based on aggregated 13F filings for Q3 2026.